Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another
Bristol Myers Squibb reported a Phase 3 success and a pipeline cut as part of its second-quarter earnings Friday morning.
The company said a pivotal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
